{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "decreases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uniprot:P25063",
      "entity_text" : "CD24",
      "entity_type" : "protein"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "pubchem:969516",
      "entity_text" : "curcumin",
      "entity_type" : "simple_chemical"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "A novel micelle formulation of curcumin, composed of stearic acid-g-chitosan oligosaccharide (CSO-SA) as a polymeric, biocompatible, and biodegradable drug carrier, inhibited CD44 + / CD24 + colorectal CSCs in vitro and in vivo (nude mice xenografts), the latter at a dose of 2 mg/kg daily for 14 days in a 15-day experiment.",
  "reading_complete" : "2020-08-09T07:07:55Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-09T07:02:52Z",
  "trigger" : "inhibited",
  "evidence" : [ "curcumin, composed of stearic acid-g-chitosan oligosaccharide (CSO-SA) as a polymeric, biocompatible, and biodegradable drug carrier, inhibited CD44 + /CD24" ],
  "pmc_id" : "7122321",
  "score" : 0
}